AcarJ. F.: Current concepts and the role of newer agents in the treatment of urinary infection. Symposium: Norfloxacin, a new oral antibacterial in the treatment of urinary tract infections. Dubrovnik, sett. 1982.
2.
a) BolognaM.: Norfloxacin in the treatment of urinary tract infections. Symposium: Norfloxacin, a new oral antibacterial in the treatment of urinary tract infections. Dubrovnik, sett. 1982.
3.
b) BolognaM.: Concentrazioni prostatiche di norflossacina con metodo HPLC. Preatti XIII Congr. Naz. Soc. Ital. Chemiot., Catania 9–11 giugno 1983. Chemioterapia, 2; suppl. 3, 193 (1973).
4.
ConsoliC.: La norflossacina nel trattamento delle infezioni urinarie. Preatti XIII Congr. Soc. Ital. Chemiot., Catania 9–11 giugno 1983. Chemioterapia, 2; suppl. 3, 195 (1983).
5.
DowsJ.: In vitro activity of MK-0366 against clinical urinary pathogens including Gentamicin-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 21; 670 (1982).
6.
GadebushH. H.: Norfloxacin (MK 0366, AM-715), a new orally absorbed synthetic compound for the treatment of bacterial infections. Proc. 12th Intern. Congr. Chemother., 1; 351 (1981).
7.
GiamarellouH.: Norfloxacin in the treatment of recurrent urinary tract infections. Symposium: Norfloxacin, a new oral antibacterial in the treatment of urinary tract infections. Dubrovnik, sett. 1982.
8.
GuerraJ. G.: Norfloxacin vs Cotrimoxazole in infections of the kidney. Symposium: Norfloxacin, a new oral antibacterial in the treatment of urinary tract infections, Dobrovnik, sett. 1982.
9.
ItoA.: In vitro antibacterial activity of AM-715, a new nalidixic acid analogous. Antimicrob. Agents Chemother., 17; 103 (1980).
10.
KhanM. Y.: Comparative in vitro activity of Norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolate. Antimicrob. Agents Chemother., 21; 848 (1982).
11.
KumamotoY.: Clinical experience with norfloxacin in urinary tract infections. Symposium: Norfloxacin, a new oral antibacterial in the treatment of urinary tract infections. Dubrovnik, sett. 1982.
12.
MattinaR., BellottiM. G.: Caratteristiche microbiologiche della norflossacina in paragone ad altri composti. Preatti XIII Congr. Naz. Soc. Ital. Chemioter., Catania 9–11 giugno 1983. Chemioterapia, 2; suppl. 3, 327 (1983).
13.
Merk Sharp & Dohme Research Laboratories, MK-0366 Investigator's Brochure, 1981.
14.
MenozziM. G.: Attività in vitro di norflossacina su ceppi multiresistenti d'isolamento clinico: confronto con altri 19 antibiotici. Preatti XIII Congr. Naz. Soc. Ital. Chemioter., Catania 9–11 giugno 1983. Chemioterapia, 2; suppl. 3, 372 (1983).
15.
MoroniM.: Esperienze cliniche con norflossacina nel trattamento di infezioni urinarie da enterobatteri e Pseudomonas. Preatti XIII Congr. Naz. Soc. Ital. Chemioter., Catania 9–11 giugno 1983. Chemioterapia, 2; suppl. 3, 197 (1983).
16.
NeuH. C., LabthavikulP.: In vitro activity of Norfloxacin, a quinolinecarboxilic acid, compared with that of beta-lactams, aminoglycosides and Trimethoprim. Antimicrob. Agents Chemother., 22; 23 (1982).
17.
NewsonS. W.: The microbial activity of Norfloxacin. Symposium: Norfloxacin, a new oral antibacterial in the treatment of urinary tract infections. Dubrovnik, sett. 1982.
18.
NorrbyS. R., RylanderM.: Pharmacokinetics of Norfloxacin: clinical implication. Symposium: Norfloxacin, a new oral antibacterial in the treatment of urinary tract infections. Dubrovnik, sett. 1982.
19.
a) PanichiG., TestoreG. P.: The treatment of urinary tract infections (multiple resistant strains) with Norfloxacin. Symposium: Norfloxacin, a new oral antibacterial in the treatment of urinary tract infections. Dubrovnik, sett. 1982.
20.
b) PanichiG.: La norflossacina: un nuovo chemioterapico orale attivo su cocchi e Gram-negativi pluriresistenti. Indirizzi razionali di terapia. Preatti XIII Congr. Naz. Soc. Ital. Chemioter., Catania 9–11 giugno 1983. Chemioterapia, 2; suppl. 3, 198 (1983).
21.
RenziniG.: Attività microbiologica della norflossacina. Preatti XIII Congr. Naz. Soc. Ital. Chemioter., Catania 9–11 giugno 1983. Chemioterapia, 2; suppl. 3, 190 (1983).
22.
RonaldA.: Norfloxacin, potential for future development. Symposium: Norfloxacin, a new oral antibacterial in the treatment of urinary tract infections. Dubrovnik, sett. 1982.
23.
RosenthalE. J., LinzenmeyerG.: In vitro activity of Norfloxacin compared with Nitrofurantoin, Nalidixin acid and Pipemidic acid (comunicaz. M.S.D.).
24.
SegreG.: Farmacocinetica della norflossacina. Preatti XIII Congr. Naz. Soc. Ital. Chemioter., Catania 9–11 giugno 1983. Chemioterapia, 2; suppl. 3, 193 (1983).
25.
SperanzaV.: Terapia delle infezioni biliari con norflossacina. Preatti XIII Congr. Naz. Soc. Ital. Chemioter., Catania 9–11 giugno 1983. Chemioterapia, 2; suppl. 3, 194 (1983).